Joell J. Gills

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

Kristin J. Lastwika, Willie Wilson, Qing Kay Li et al. · Cancer Research · 2015 · 764 citations

Immunology, Immune Regulation, Immunoediting +20

Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis <i>In vitro</i> and <i>In vivo</i>

Joell J. Gills, Jaclyn LoPiccolo, Junji Tsurutani et al. · Clinical Cancer Research · 2007 · 326 citations

Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells

Junji Tsurutani, S. Sianna Castillo, John Brognard et al. · Carcinogenesis · 2005 · 287 citations · Full text

Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy

Joell J. Gills, Jaclyn LoPiccolo, Phillip A. Dennis · Autophagy · 2008 · 132 citations

Many Paths, Mitophagy, Hiv Protease Inhibitors +22

Inhibition of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway but not the MEK/ERK Pathway Attenuates Laminin-Mediated Small Cell Lung Cancer Cellular Survival and Resistance to Imatinib Mesylate or Chemotherapy

Junji Tsurutani, Kip A. West, Jacqueline Sayyah et al. · Cancer Research · 2005 · 123 citations

Sclc Resistance, Immunology, Cancer Biology +16